Raleigh Capital Management Inc. Has $89,000 Stock Position in Colgate-Palmolive (NYSE:CL)

Raleigh Capital Management Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 52.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 856 shares of the company’s stock after acquiring an additional 293 shares during the quarter. Raleigh Capital Management Inc.’s holdings in Colgate-Palmolive were worth $89,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the second quarter worth $25,000. Continuum Advisory LLC raised its position in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Register Financial Advisors LLC acquired a new position in Colgate-Palmolive during the 1st quarter worth about $48,000. Gradient Investments LLC grew its position in shares of Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after buying an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. acquired a new position in shares of Colgate-Palmolive in the second quarter worth approximately $68,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL opened at $99.68 on Wednesday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The business’s fifty day moving average is $103.38 and its 200 day moving average is $97.83. The company has a market capitalization of $81.78 billion, a PE ratio of 31.54, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.77 EPS. Sell-side analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.01%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Analyst Ratings Changes

CL has been the subject of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. TD Cowen raised their price objective on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Finally, Morgan Stanley boosted their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.00.

Insider Activity

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.